publication venue for
- Sofosbuvir-velpatasvir for 12 weeks is safe and effective in patients undergoing dialysis 2019
- Efficacy of injection naloxone hydrochloride for the management of acute colonic pseudoobstruction 2016
- Initial experience with naloxone hydrochloride for the treatment of acute intestinal pseudoobstruction in intensive care unit (ICU) patients 2015
- Malignant melanoma of the stomach and duodenum presenting with gastric outlet obstruction: Report of a rare case 2015
- Dependence of colonic motor patterns on 5-HT3 and 5-HT4 receptor activation in the rat 2013
- Functional association of MDM2 binding protein with metastatic potential of hepatocellular carcinoma 2013
- Percutaneous gastric slow wave signal characteristics in functional gastrointestinal disorders 2013
- TENS improves constipation symptoms and quality of life in patients with slow transit constipation 2013
- PPI and antiplatelet Co-therapy: What does the current evidence show? 2012
- Potential roles for interstitial cells of Cajal in the pathophysiology of irritable bowel Syndrome 2011
- Prevalence and significance of nonalcoholic fatty liver disease in adolescent girls with polycystic ovary syndrome 2011
- Efficacy and safety of entecavir (ETV) vs. adefovir (ADV) in chronic hepatitis B (CHB) patients with evidence of hepatic decompensation: ETV-048 study 2010
- Association between nonalcoholic fatty liver disease and coronary artery calcification 2009
- Benign biliary stricture managed with Gianturco-Rosch Z self-expanding metallic stent 2009
- Transient elastography (Fibroscan) in chronic hepatitis B infection: reduce number of biopsies & save money 2009
- High retinol binding protein-4 and low adiponectin levels are associated with steatosis in bariatric patients 2008
- Prevalence and significance of the endoscopic diagnosis of portal hypertension 2008
- Helicobacter pylori and related disease 2007
- Baseline analysis of symptom spectrum in GORD: results from ReQuest (TM) database 2006
- International GORD symptom thresholds based on the ReQuest (TM) questionnaire definition of symptom relief in clinical studies 2006
- Ustekinumab does not increase risk of new or recurrent cancer in inflammatory bowel disease patients with prior malignancy. 37:1016-1021. 2022
- Comparative effectiveness of higher adalimumab maintenance therapy versus standard dose in anti‐tumor necrosis factor experienced Crohn's disease patients: A propensity‐score matched cohort analysis. 36:2803-2812. 2021
- Systematic review and meta‐analysis: Safety of vedolizumab during pregnancy in patients with inflammatory bowel disease. 36:2640-2648. 2021
- Adverse metabolic phenotype of adolescent girls with non‐alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys. 31:980-987. 2016
-
Gastroenterology: Revisiting the forgotten sign: Five layered gut signature and
Y configuration in enteric duplication cysts on high resolution ultrasound. 30:1111-1111. 2015 -
Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti‐tuberculosis agents in a large cohort of
C hinese patients. 30:540-545. 2015 - Does acetylsalicylic acid or warfarin affect the accuracy of fecal occult blood tests?. 28:931-936. 2013
- Hepato‐biliary clinical trials and their inclusion in the Cochrane Hepato‐Biliary Group register and reviews. 26:649-656. 2011
- Role of probiotics in management of diverticular disease. 25:1827-1830. 2010
- Proton pump inhibitor and clopidogrel interaction: The case for watchful waiting. 25:1342-1347. 2010
- Second Asia–Pacific Consensus Guidelines for Helicobacter pylori infection. 24:1587-1600. 2009
- Chronic hepatitis B infection in an Australian antenatal population: seroprevalence and opportunities for better outcomes. 24:998-1001. 2009
- Effects of muscarinic receptor stimulation and nitric oxide synthase inhibition on gastric tone and gastric myoelectrical activity in canines. 24:1130-1135. 2009
- Asia–Pacific consensus guidelines on gastric cancer prevention. 23:351-365. 2008
- Corrigendum. 23:504-504. 2008
- Asia‐Pacific consensus on the management of gastroesophageal reflux disease: Update. 23:8-22. 2008
- Multiple viral hepatitis in injection drug users and associated risk factors. 22:80-85. 2007
- Proton pump inhibitors in acute non‐variceal upper gastrointestinal bleeding. 21:1763-1765. 2006
- Report of the Asia–Pacific consensus on the management of gastroesophageal reflux disease. 19:357-367. 2004
- Has education about Helicobacter pylori infection been effective? Worldwide survey of primary care physicians. 18:512-520. 2003
- Helicobacter pylori: From art to a science. 13:21-28. 1998
-
R
eview: Eradication of Helicobacter pylori. Problems and recommendations. 12:590-598. 1997 - Sucralfate: The Bangkok review. 9:412-415. 1994
- Prevalence of hepatitis C infection in Hong Kong. 7:117-120. 1992